IDEAYA Biosciences Financials - Benzinga

IDEAYA Biosciences Inc

IDYANASDAQ

Trade with Public

Trade with Public

$39.71

-0.39-0.97%

마지막 업데이트: Sep 1, 9:50 AM

개요 뉴스 실적 전망 이벤트 목표가재무심리 지분 현황 비교 옵션 주식 보고서

IDEAYA Biosciences Financials

IDEAYA Biosciences (IDYA) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
IDEAYA Biosciences Q2 EPS $(1.22) Misses $(1.09) Estimate, Sales $8.857M Beat $5.015M Estimate

IDEAYA Biosciences (NASDAQ:IDYA) reported quarterly losses of $(1.22) per share which missed the analyst consensus estimate of $(1.09) by 11.93 percent. This is a 38.64 percent decrease over losses of $(0.88) per share

Benzinga Newsdesk

Earnings Scheduled For May 5, 2026

Benzinga Insights

PRO
IDEAYA Biosciences Q1 EPS $(1.11) Misses $(0.98) Estimate, Sales $6.560M Beat $5.008M Estimate

IDEAYA Biosciences (NASDAQ:IDYA) reported quarterly losses of $(1.11) per share which missed the analyst consensus estimate of $(0.98) by 13.27 percent. This is a 35.37 percent decrease over losses of $(0.82) per share

Benzinga Newsdesk

Stock Market Today: Dow Futures Fall As Trump Announces Strait Of Hormuz Blockade—Goldman Sachs, Fastenal In Focus (UPDATED)

Editor’s note: The future prices of benchmark tracking ETFs and pre-market prices of stocks have been updated. U.S. stock futures declined on Monday following Friday's mixed close. Futures of major benchmark indices were lower after President Donald Trump announced a blockade of the Strait of Hormuz.

Benzinga Neuro

Earnings Scheduled For February 17, 2026

Benzinga Insights

IDEAYA Biosciences Q4 Earnings Report: What Investors Need to Know

Benzinga Insights

© 2026 Benzinga | All Rights Reserved